-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation